Rivanna Medical, Inc.

Rivanna Medical, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on May 23, 2025 and the most recent on May 23, 2025 (Accuro 3S). Its most common review panel is Radiology (1 device).